The Pre-Filled Syringes Market Size, Share, Growth, Trend & Forecast to 2015 – 2030: Radiant Insights, Inc A pre-filled syringe is a medical syringe that comes pre-filled with a specific dosage of medication. Representing one of the fastest growing segments of the injectable drug delivery ecosystem, pre-filled syringes offer significant benefits over the traditional „vial and syringe‟ format, by increasing dosing accuracy, safety and convenience. In addition, pre-filled syringes also offer a variety of economic benefits to pharmaceutical companies including a reduction in drug overfill and waste, which increases the saleable yield of the API (Active Pharmaceutical Ingredient). Read Complete Report with TOC @ http://www.radiantinsights.com/research/the-pre-filledsyringes-market-2015-2030-opportunities-challenges-strategies-forecasts SNS Research estimates that the market for pre-filled syringes will account for over $3.2 Billion in revenue by the end of 2015. Despite challenges relating to drug stability, manufacturing and competition from other drug delivery technologies, the market is poised for significant growth in the coming years. Expected to grow at a CAGR of 13% between 2015 and 2020, the market will account for nearly $6 Billion in revenue by the end of 2020. The “Pre-Filled Syringes Market: 2015 – 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of the pre-filled syringes ecosystem including technology, market drivers, challenges, investment potential, leading therapies, use cases, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents market size forecasts for pre-filled syringe unit sales from 2015 through to 2030. The forecasts are further segmented for 4 horizontal submarkets, 10 drug classes, 5 regions and 13 leading countries. The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.
Key Findings: The report has the following key findings: SNS Research estimates that the market for pre-filled syringes will account for over $3.2 Billion in revenue by the end of 2015. Expected to grow at a CAGR of 13% between 2015 and 2020, the market will account for nearly $6 Billion in revenue by the end of 2020 Many pre-filled syringe manufacturers now also offer integrated automatic needle shielding or retractable needle options
While glass continues to remain the gold standard for pre-filled syringes, the proportion of plastic based pre-filled syringes is expected to increase by 5% between 2015 and 2020, due to concerns of glass breakage and plunger failure A number of pre-filled syringe manufacturers have developed dual and multi chambered syringes, to cater for drugs that must be reconstituted at the point of delivery Pre-filled pen systems and auto-injectors will grow at a CAGR of more than 20% over the next five years Read Complete Report with TOC @ http://www.radiantinsights.com/research/the-pre-filledsyringes-market-2015-2030-opportunities-challenges-strategies-forecasts Topics Covered: The report covers the following topics: Pre-filled syringes ecosystem Market drivers and barriers Technology, safety mechanisms and key trends Pen systems and auto-injectors Industry roadmap and value chain Analysis of leading drug classes and pre-filled syringe therapies Profiles and strategies of 55 leading ecosystem players, including manufacturers and pharmaceutical giants Strategic recommendations for ecosystem players Market analysis and forecasts from 2015 till 2030 Table of Contents
1 Chapter 1: Introduction 1.1 Executive Summary 1.2 Topics Covered 1.3 Historical Revenue & Forecast Segmentation 1.4 Key Questions Answered 1.5 Key Findings
1.6 Methodology 1.7 Target Audience 1.8 Companies & Organizations Mentioned 2 Chapter 2: An Overview of Pre-filled Syringes 2.1 A Brief History of Pre-Filled Syringes 2.2 Types of Pre-Filled Syringes 2.2.1 Glass based 2.2.2 Plastic based 2.2.3 Glass vs. Plastic: A Comparison 2.3 Needle Configuration in Pre-Filled Syringes Read Complete Report with TOC @ http://www.radiantinsights.com/research/the-pre-filledsyringes-market-2015-2030-opportunities-challenges-strategies-forecasts 2.3.1 Staked-In Needles 2.3.2 Luered Designs 2.4 Single vs. Multi Chamber Syringes 2.4.1 Single Chamber Syringes 2.4.2 Dual & Multi Chamber Syringes 2.5 Safety Concerns of Pre-Filled Syringes 2.5.1 Regulation Driving Safety-Engineered Devices 2.5.2 Traditional Safety Mechanisms 2.5.3 Modern Solutions & Future Prospects 2.6 Pen Systems and Auto-Injectors: Towards Self-Administration 2.6.1 Pen Systems 2.6.2 Auto-Injectors 2.6.3 Future Prospects 2.7 Market Growth Drivers
2.7.1 Ease of Use: Towards At-Home Care & Self-Administration 2.7.2 Cost Containment & Changing Medical Practices 2.7.3 Decreased Risk of Contamination 2.7.4 Decreased Risk of Needle-Stick Injuries 2.7.5 Reduction in Drug Overfill & Waste: Lowering the Cost Per Dosage Unit 2.7.6 Product Differentiation Read Complete Report with TOC @ http://www.radiantinsights.com/research/the-pre-filledsyringes-market-2015-2030-opportunities-challenges-strategies-forecasts 2.7.7 Logistical Benefits: Ease of Storage and Shipping 2.8 Market Barriers 2.8.1 Drug Stability & Product Shelf Life 2.8.2 Plunger-Barrel Design Challenges 2.8.3 Material Concerns: Glass vs. Plastic 2.8.4 Challenges from Other Drug Delivery Systems 2.8.5 Regulatory, Quality Control & Safety Challenges
3 Chapter 3: Drug Class Availability & Leading Therapies 3.1 Drug Class Availability in Pre-Filled Syringes 3.1.1 MAbs (Monoclonal Antibodies) 3.1.2 Insulin 3.1.3 Erythropoietins 3.1.4 Interferons 3.1.5 G-CSF agents 3.1.6 Anticoagulants 3.1.7 Recombinant Coagulation Factors 3.1.8 Biosimilars and Follow-on Protein Products
3.1.9 Vaccines 3.1.10 Growth Hormones 3.2 Leading Pre-Filled Syringe Based Therapies 3.2.1 Insulin Therapies 3.2.1.1 Apipara (Insulin Glulisine) 3.2.1.2 Lantus (Insulin Glargine) 3.2.1.3 Levemir (Insulin Detemir) 3.2.1.4 NovoLog (Insulin Aspart) Read Complete Report with TOC @ http://www.radiantinsights.com/research/the-pre-filledsyringes-market-2015-2030-opportunities-challenges-strategies-forecasts 3.2.1.5 Humalog (Insulin Lispro) 3.2.2 Rheumatoid Arthritis 3.2.2.1 Humira (Adalimumab) 3.2.2.2 Enbrel (Etanercept) 3.2.3 MS (Multiple Sclerosis) 3.2.3.1 Copaxone (Glatiramer Acetate) 3.2.3.2 Avonex, Rebif & CinnoVex (Interferon Beta 1a) 3.2.4 Growth Hormones 3.2.4.1 Somatropin (Various Brands) 3.2.5 Anticoagulants: Low Weight Molecular Herapins 3.2.5.1 Enoxaparin (Various Brands) 3.2.5.2 Arixtra (Fondaparinux) 3.2.5.3 Fragmin (Dalteparin Sodium)
4 Chapter 4: Pre-Filled Syringes Industry Roadmap & Value Chain 4.1 Industry Roadmap
4.1.1 2015 – 2020: Moving Towards Plastic Based Syringes 4.1.2 2020 – 2025: Continued R&D Investments: Enhancing Safety Measures 4.1.3 2025 – 2030 & Beyond: Significant Competition from Needle-Free Delivery Technologies 4.2 Value Chain 4.2.1 Raw Material & Component Providers 4.2.2 Pre-Filled Syringe Manufacturers 4.2.1 Pharmaceutical Companies & Contract Fillers 4.2.2 Healthcare Providers, Pharmacies & Drug Stores Read Complete Report with TOC @ http://www.radiantinsights.com/research/the-pre-filledsyringes-market-2015-2030-opportunities-challenges-strategies-forecasts 5 Chapter 5: Key Market Players 5.1 Abbott Laboratories 5.2 Amgen 5.3 AMRI (Albany Molecular Research, Inc.) 5.4 Aptar Stelmi 5.5 Artemes Technologies 5.6 AstraZeneca 5.7 Battelle 5.8 Baxter International 5.9 BD (Becton, Dickinson and Company) 5.10 Biocon 5.11 Boehringer Ingelheim 5.12 BSM (Bristol-Myers Squibb) 5.13 Consort Medical 5.14 Catalent Pharma Solutions 5.15 Coldstream Laboratories
5.16 Daiko Seiko 5.17 Dätwyler Holding 5.18 Elcam Medical 5.19 Eli Lilly and Company 5.20 Fischer Clinical Services 5.21 Gerresheimer 5.22 GSK (GlaxoSmithKline) 5.23 Haselmeier 5.24 Hospira 5.25 Johnson & Johnson 5.26 Laboratorios FarmacÊuticos ROVI Read Complete Report with TOC @ http://www.radiantinsights.com/research/the-pre-filledsyringes-market-2015-2030-opportunities-challenges-strategies-forecasts 5.27 LTI (Lyophilization Technology, Inc.) 5.28 MedPro Safety Products 5.29 Medtronic 5.30 Medilet 5.31 Merck and Co. 5.32 Nipro Corporation 5.33 Novartis International 5.34 Novo Nordisk 5.35 Ompi (Stevanato Group) 5.36 Owen Mumford 5.37 PA Consulting 5.38 Pfanstiehl 5.39 Pfizer
5.40 Revolutions Medical Corporation 5.41 Roche Holding (F. Hoffmann-La Roche) 5.42 Roselabs 5.43 Sanofi 5.44 Schott 5.45 SHL Group 5.46 Takeda Pharmaceutical Company 5.47 Terumo Corporation Read Complete Report with TOC @ http://www.radiantinsights.com/research/the-pre-filledsyringes-market-2015-2030-opportunities-challenges-strategies-forecasts 5.48 Teva Pharmaceutical Industries 5.49 Unilife Corporation 5.5 Vetter Pharma (Vetter Pharma-Fertigung GmbH & Co. KG) 5.51 Weigao Group (Shandong Weigao Group Medical Polymer Co.) 5.52 West Pharmaceutical Services 5.53 Ypsomed Holding 5.54 Yukon Medical 5.55 Zogenix
6 Chapter 6: Market Analysis & Forecasts 6.1 Global Outlook of Pre-Filled Syringes 6.2 Segmentation by Material 6.2.1 Glass Based 6.2.2 Plastic Based 6.3 Segmentation by Injector Type 6.3.1 Conventional
6.3.2 Pen Systems & Auto-Injectors 6.4 Segmentation by Drug Class 6.4.1 MAbs (Monoclonal Antibodies) 6.4.2 Insulins 6.4.3 Erythropoietins 6.4.4 Interferons 6.4.5 G-CSF Agents 6.4.6 Anticoagulants & Recombinant Coagulations Factors 6.4.7 Biosimilars & Follow-On Protein Products Read Complete Report with TOC @ http://www.radiantinsights.com/research/the-pre-filledsyringes-market-2015-2030-opportunities-challenges-strategies-forecasts 6.4.8 Growth Hormones 6.4.9 Vaccines 6.4.10 Other Drug Classes 6.5 Segmentation by Region 6.5.1 Asia Pacific 6.5.2 Europe 6.5.3 Middle East & Africa 6.5.4 Latin & Central America 6.5.5 North America 6.6 Top Country Markets 6.6.1 Brazil 6.6.2 Canada 6.6.3 China 6.6.4 France 6.6.5 Germany
6.6.6 India 6.6.7 Italy 6.6.8 Japan 6.6.9 Korea 6.6.10 Russia 6.6.11 Spain 6.6.12 UK 6.6.13 USA Read Complete Report with TOC @ http://www.radiantinsights.com/research/the-pre-filledsyringes-market-2015-2030-opportunities-challenges-strategies-forecasts 7 Chapter 7: Conclusion & Strategic Recommendations 7.1 Why is the Market Poised to Grow? 7.2 Changing Medical Practices: Fueling Demand for Pre-Filled Syringes 7.3 Product Differentiation: Switching from Vials to Pre-Filled Syringes 7.4 Growing Proliferation of Embedded Safety Features 7.5 Patent Expiries for Biologics: Prospects for the Pre-Filled Syringes Market 7.6 Impact of Regulation: Usability & Safety Concerns 7.7 Prospects of Dual & Multi Chamber Syringes 7.8 Strategic Recommendations 7.8.1 Shelf Life & Lead Timing 7.8.2 Adapting to Pharmaceutical & Biotechnology Innovations 7.8.3 Battling the Threat from Alternative Drug Delivery Systems 7.8.4 Developing Product Differentiation 7.8.5 Incorporating Human-Centric Usability Aspects 7.8.6 Considering Alternatives to Glass About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. For More Information, Visit Radiant Insights Contact: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: sales@radiantinsights.com Blog URL: http://chemicalmaterialsmarket.blogspot.in/